United States securities and exchange commission logo





                           October 7, 2020

       Kathryn Andrews
       Chief Financial Officer
       Alterity Therapeutics Ltd.
       ABN 37 080 699 065
       Level 3, 460 Bourke Street
       Melbourne, Victoria 3000 Australia

                                                        Re: Alterity
Therapeutics Ltd.
                                                            Registration
Statement on Form F-3
                                                            Filed October 5,
2020
                                                            File No. 333-249311

       Dear Ms. Andrews:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Laura
Crotty at 202-551-7614 with any questions.




                           Sincerely,


                           Division of Corporation Finance

                           Office of Life Sciences
       cc:                                              Steven J. Glusband